141 related articles for article (PubMed ID: 31130393)
1. Pharmacokinetic-pharmacodynamic comparison of ceftriaxone regimens in acute cholangitis.
Toki M; Yamaguchi Y; Goto T; Yoshida T; Ota H; Ochiai K; Gondo K; Watanabe S; Kurata I; Hisamatsu T
J Infect Chemother; 2019 Oct; 25(10):780-785. PubMed ID: 31130393
[TBL] [Abstract][Full Text] [Related]
2. [Ceftriaxone versus Levofloxacin for antibiotic therapy in patients with acute cholangitis].
Kiesslich R; Will D; Hahn M; Nafe B; Genitsariotis R; Mäurer M; Jung M
Z Gastroenterol; 2003 Jan; 41(1):5-10. PubMed ID: 12541165
[TBL] [Abstract][Full Text] [Related]
3. Predicting the clinical efficacy of generic formulations of ceftriaxone.
Schito GC; Keenan MH
J Chemother; 2005 Sep; 17 Suppl 2():33-40. PubMed ID: 16315582
[TBL] [Abstract][Full Text] [Related]
4. [Interventional ERCP in patients with cholestasis. Degree of biliary bacterial colonization and antibiotic resistance].
Kiesslich R; Holfelder M; Will D; Hahn M; Nafe B; Genitsariotis R; Daniello S; Maeurer M; Jung M
Z Gastroenterol; 2001 Dec; 39(12):985-92. PubMed ID: 11753782
[TBL] [Abstract][Full Text] [Related]
5. Pharmacodynamics of Ceftaroline plus Ampicillin against Enterococcus faecalis in an
Werth BJ; Shireman LM
Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28096164
[TBL] [Abstract][Full Text] [Related]
6. [Comparison of efficacy between ceftriaxone and cefoperazone plus sulbactam in peri-operative treatment of acute suppurative cholangitis].
Zhou XS; Zou SQ; Dong JH; Wu WZ; Zhang YD; Zhang TL; Zeng Z; Li NF; Man GT
Zhonghua Yi Xue Za Zhi; 2004 Nov; 84(22):1879-82. PubMed ID: 15631798
[TBL] [Abstract][Full Text] [Related]
7. Indications for a ceftriaxone dosing regimen in Japanese paediatric patients using population pharmacokinetic/pharmacodynamic analysis and simulation.
Iida S; Kawanishi T; Hayashi M
J Pharm Pharmacol; 2011 Jan; 63(1):65-72. PubMed ID: 21155817
[TBL] [Abstract][Full Text] [Related]
8. How can we predict bacterial eradication?
Jacobs MR
Int J Infect Dis; 2003 Mar; 7 Suppl 1():S13-20. PubMed ID: 12839703
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and pharmacodynamic target attainment of ceftriaxone in adult severely ill sub-Saharan African patients: a population pharmacokinetic modelling study.
Bos JC; Prins JM; Mistício MC; Nunguiane G; Lang CN; Beirão JC; Mathôt RAA; van Hest RM
J Antimicrob Chemother; 2018 Jun; 73(6):1620-1629. PubMed ID: 29522167
[TBL] [Abstract][Full Text] [Related]
10. Limitations of ceftriaxone compared with cefazolin against MSSA: an integrated pharmacodynamic analysis.
Zelenitsky SA; Beahm NP; Iacovides H; Ariano RE; Zhanel G
J Antimicrob Chemother; 2018 Jul; 73(7):1888-1894. PubMed ID: 29635472
[TBL] [Abstract][Full Text] [Related]
11. Bacteriological study of choledochal bile in patients with common bile duct stones, with or without acute suppurative cholangitis.
Maluenda F; Csendes A; Burdiles P; Diaz J
Hepatogastroenterology; 1989 Jun; 36(3):132-5. PubMed ID: 2502489
[TBL] [Abstract][Full Text] [Related]
12. Linezolid pharmacokinetic/pharmacodynamic profile in critically ill septic patients: intermittent versus continuous infusion.
Adembri C; Fallani S; Cassetta MI; Arrigucci S; Ottaviano A; Pecile P; Mazzei T; De Gaudio R; Novelli A
Int J Antimicrob Agents; 2008 Feb; 31(2):122-9. PubMed ID: 18055183
[TBL] [Abstract][Full Text] [Related]
13. Cholangiosepsis: endoscopic drainage and antibiotic therapy.
Leung JW; Venezuela RR
Endoscopy; 1991 Jul; 23(4):220-3. PubMed ID: 1915139
[No Abstract] [Full Text] [Related]
14. Pharmacokinetics and Pharmacodynamics of Temocillin.
Alexandre K; Fantin B
Clin Pharmacokinet; 2018 Mar; 57(3):287-296. PubMed ID: 28849402
[TBL] [Abstract][Full Text] [Related]
15. [Changes in antibiotic resistance in cholangitis.
Illés D; Urbán E; Lázár A; Nagy K; Ivány E; Kui B; Lemes K; Tajti M; Czakó L
Orv Hetil; 2019 Sep; 160(36):1437-1442. PubMed ID: 31492084
[TBL] [Abstract][Full Text] [Related]
16. Procalcitonin as a Decision-Supporting Marker of Urgent Biliary Decompression in Acute Cholangitis.
Lee YS; Cho KB; Park KS; Lee JY; Lee YJ
Dig Dis Sci; 2018 Sep; 63(9):2474-2479. PubMed ID: 29480416
[TBL] [Abstract][Full Text] [Related]
17. Tokyo Guidelines 2018: initial management of acute biliary infection and flowchart for acute cholangitis.
Miura F; Okamoto K; Takada T; Strasberg SM; Asbun HJ; Pitt HA; Gomi H; Solomkin JS; Schlossberg D; Han HS; Kim MH; Hwang TL; Chen MF; Huang WS; Kiriyama S; Itoi T; Garden OJ; Liau KH; Horiguchi A; Liu KH; Su CH; Gouma DJ; Belli G; Dervenis C; Jagannath P; Chan ACW; Lau WY; Endo I; Suzuki K; Yoon YS; de Santibañes E; Giménez ME; Jonas E; Singh H; Honda G; Asai K; Mori Y; Wada K; Higuchi R; Watanabe M; Rikiyama T; Sata N; Kano N; Umezawa A; Mukai S; Tokumura H; Hata J; Kozaka K; Iwashita Y; Hibi T; Yokoe M; Kimura T; Kitano S; Inomata M; Hirata K; Sumiyama Y; Inui K; Yamamoto M
J Hepatobiliary Pancreat Sci; 2018 Jan; 25(1):31-40. PubMed ID: 28941329
[TBL] [Abstract][Full Text] [Related]
18. Microbial profile and antibiotic sensitivity pattern in acute bacterial cholangitis.
Sahu MK; Chacko A; Dutta AK; Prakash JA
Indian J Gastroenterol; 2011 Sep; 30(5):204-8. PubMed ID: 22006165
[TBL] [Abstract][Full Text] [Related]
19. Pharmacodynamic analysis of ceftriaxone, gatifloxacin,and levofloxacin against Streptococcus pneumoniae with the use of Monte Carlo simulation.
Frei CR; Burgess DS
Pharmacotherapy; 2005 Sep; 25(9):1161-7. PubMed ID: 16164390
[TBL] [Abstract][Full Text] [Related]
20. Challenges in assessing microbial susceptibility and predicting clinical response to newer-generation fluoroquinolones.
Segreti J; Jones RN; Bertino JS
J Ocul Pharmacol Ther; 2012 Feb; 28(1):3-11. PubMed ID: 21999341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
